• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Model Number UNK-CV-SR-ENDUR-II
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Inflammation (1932); Thrombocytopenia (4431); Thrombosis/Thrombus (4440); Respiratory Insufficiency (4462)
Event Date 03/24/2022
Event Type  Injury  
Manufacturer Narrative
Medtronic received the following information from a journal article entitled; comparison study of iliac branch endoprosthesis when used on and off label rodriguez l.E., eun j.C., calkins r.T., carroll a.M., malgor e.A., wohlauer m.V., nehler m.R., jacobs d.L., malgor r.D.Ann.Vasc.Surg.2023 feb 01; 89:28-35.Doi: 10.1016/j.Avsg.2022.03.015 a2.<(>&<)> if information is provided in the future, a supplemental report will be issued.
 
Event Description
A non mdt iliac branch endoprosthesis was implanted in a patient for the treatment of a ib endoleak in an endurant iis stent graft.Other patients were implanted with iliac branch endoprostheses to treat common iliac artery aneurysms.Patients were treated at two centers over a four year period and outcomes were compared between ifu and non ifu iliac branch endoprosthesis (ibe) cases.The treatment of the ib endoleak in the endurant stent graft was considered a off label technique.In the follow-up period in the non ifu group the following malfunctions were identified; type iii endoleaks the following adverse events were identified; one internal iliac artery limb thrombosis, hematoma, minor systemic complications ( mild respiratory insufficiency, 150% rise in cr eatinine, post implantation syndrome, and/or heparin induced thrombocytopenia which were managed medically), intervention patient mortality was reported but there is no causal link that an endurant stent graft caused or contributed to a death.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II STENT GRAFT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key16813457
MDR Text Key313989412
Report Number9612164-2023-01772
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-CV-SR-ENDUR-II
Device Catalogue NumberUNK-CV-SR-ENDUR-II
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/03/2023
Initial Date FDA Received04/26/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
Patient SexMale
-
-